Skip to content
Screener

LeMaitre Vascular LMAT Q2 2026 earnings

Reported August 4, 2026 · After market close

Revenue$70.4MMiss by $1.1M
EPS$0.74Miss by $0.07
Revenue estimate$71.5M
EPS estimate$0.81
“Our focus on the Artegraft international launch paid off in Q2. The product is now approved in 56 countries, accounting for 21% of sales. So our largest product is now our fastest-growing product. To underpin the Artegraft launch and pave the way for RFA, we continue to build our sales force, go direct in new countries and we're now undertaking six international warehouse expansions. $376m of cash provides strategic optionality.”
George LeMaitre

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$67.4M
EPS estimate$0.69

Financials

Q2 2026

Income statement

See full
Revenue$70.4M+9.6%
Gross profit$50.8M+12.9%
Operating income$20.4M+26.4%
Net income$17.1M+23.7%
EPS (diluted)$0.74+23.3%

Balance sheet

See full
Cash & equivalents$26.6M-2.0%
Total debt$21.2M+19.7%
Total equity$420.3M+15.9%
Total assets$640.5M+10.9%

Cash flow

See full
Operating cash flow$16.0M-21.3%
CapEx$2.3M+72.4%
Free cash flow$13.7M-28.0%

Valuation & ratios

Valuation

as of 09/17/26
See full
Market cap$1.84B-11.8%
Enterprise value$1.83B-11.7%
P/E28×-16.3×
P/S7×-1.9×

Profitability

See full
Gross margin72.9%+3.8pp
Operating margin29.5%+6.1pp
Net margin25%+4.9pp
FCF margin28.1%+5.8pp

Returns & leverage

See full
Return on equity16.8%+3.0pp
Debt / equity0.1×0.0×
Current ratio16.3×+2.4×

FAQ

When did LeMaitre Vascular report Q2 2026 earnings?
LeMaitre Vascular (LMAT) reported Q2 2026 earnings on August 4, 2026 after market close.
What were LeMaitre Vascular's Q2 2026 revenue and EPS?
LeMaitre Vascular reported revenue of $70.4M and eps of $0.74 for Q2 2026.
Did LeMaitre Vascular beat estimates in Q2 2026?
Revenue missed the consensus estimate of $71.5M by $1.1M. EPS missed the consensus estimate of $0.81 by $0.07.
How did LeMaitre Vascular's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 9.6% from $64.2M a year earlier and eps grew 23.3% from $0.60.
Where can I find LeMaitre Vascular's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-332982) and the 10-Q periodic report (0001193125-26-333762) directly on SEC EDGAR. The filing index links above go to sec.gov.